Bio-Path Holdings to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
September 09, 2020 08:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to...
Bio-Path Holdings Reports Second Quarter 2020 Financial Results
August 14, 2020 07:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to...
Bio-Path Holdings Announces First Patient Dosed in Amended Stage 2 of the Phase 2 Clinical Trial Evaluating Prexigebersen in Acute Myeloid Leukemia
August 13, 2020 07:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
Bio-Path Holdings to Announce Second Quarter 2020 Financial Results on August 14, 2020
August 07, 2020 08:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
Bio-Path Holdings Presents at 2020 American Society of Clinical Oncology Annual Meeting
May 29, 2020 08:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, May 29, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
Bio-Path Holdings Reports First Quarter 2020 Financial Results
May 15, 2020 07:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, May 15, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop...
Bio-Path Holdings to Present at the 2020 American Society of Clinical Oncology Annual Meeting
May 13, 2020 17:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, May 13, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to...
Bio-Path Holdings to Announce First Quarter 2020 Financial Results on May 15, 2020
May 08, 2020 08:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, May 08, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to...
Bio-Path Holdings Presents at 2020 American Association for Cancer Research Annual Meeting
April 27, 2020 09:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON , April 27, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop...
Bio-Path Holdings to Present at the 2020 American Association for Cancer Research Annual Meeting
April 13, 2020 07:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, April 13, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to...